Sunesis is a biopharmaceutical company that is currently in the clinical stage of development. The company's main goal is to discover, develop, and ultimately commercialize new small molecule therapeutics that can be used for a variety of medical needs, including oncology. With a focus on innovation and research, Sunesis is poised to make a significant impact in the biopharmaceutical industry.